GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (ASX:HLS) » Definitions » Price-to-Funds-From-Operations

Healius (ASX:HLS) Price-to-Funds-From-Operations : (As of May. 01, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Healius Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Healius (ASX:HLS) Business Description

Traded in Other Exchanges
N/A
Address
161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.